| Disease | citrullinemia type ii |
| Comorbidity | C0019151|hepatic encephalopathy |
| Sentences | 2 |
| PubMedID- 20118603 | Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency. |
| PubMedID- 24234505 | It is suggested that kgm may be a useful biomarker for many hyperammonemic diseases including hepatic encephalopathy, inborn errors of the urea cycle, citrin deficiency and lysinuric protein intolerance. |
Page: 1